EGP 6,392,000
3 Bedrooms Apartment for Sale in Ever 6 October By CRED - Delivery Year 2026
CRED, a leading Egyptian pharmaceutical company, has recently launched a new compound called Ever. This innovative product is a combination of two drugs, Everolimus and Exemestane, which work together to treat breast cancer in postmenopausal women.
Everolimus is a drug that inhibits the growth of cancer cells by blocking a protein called mTOR. Exemestane, on the other hand, is an aromatase inhibitor that reduces the production of estrogen, a hormone that can stimulate the growth of breast cancer cells.
By combining these two drugs, Ever offers a more effective and targeted treatment for breast cancer. It is specifically designed for women who have already undergone surgery and other treatments, such as chemotherapy and radiation therapy, but still have a high risk of cancer recurrence.
According to Dr. Ahmed El-Morsy, the CEO of CRED, Ever is a significant breakthrough in breast cancer treatment. He stated, "We are proud to introduce Ever to the Egyptian market, which is a result of our continuous efforts to provide innovative and effective solutions to patients with cancer."
Breast cancer is the most common cancer among women worldwide, with an estimated 2.3 million new cases diagnosed in 2020 alone. In Egypt,
Ever Crowning a prime location on 26th of July Corridor, Ever is an ever-evolving vision of seamless integration and signature living on cascading levels, designed to enrich every modern lifestyle looking to settle, enjoy or simply thrive at work. The mixed-used development is artfully planned on 40 acres of lush land to introduce a variety of upscale housing types and commercial experiences that promise to last a lifetime. Crisp and contemporary in design, Ever’s first phase boasts a mix of sleek and minimalist low-rise residential units (G+4), in addition to three expansive floors dedicated to forward administrative offices, directly facing the central monorail station. Phase two will embrace contemporary high-rise buildings (G+9), offering distinctive podium commercial units, as well as fully finished office spaces on the first four levels, lending space to branded apartments that take in magical views of Zayed from above.
CRED The company’s journey has been driven by unrivaled quality standards, breakthrough designs and timely delivery, allowing it to carve for itself a competitive niche in strategic locations across Egypt to rise with its target’s ambitions to new heights. Cred focuses on a progressive model where life evolves in the form of art, thanks to holistic developments that meld the best in living, leisure, business and entertainment under one comprehensive roof. With multi-disciplinary expertise, powered by forward-thinking professionals in every field, Cred masters all facets of development to boast a successful track-record of exemplary residential and mixed-used projects that leave a timeless mark on the real estate industry for unlocking the true meaning of life, inside out.